“…Multiple computational technologies, such as molecular dynamics (MD) simulations [ 25 , 26 , 27 , 28 , 29 , 30 ], calculations of binding free energies [ 31 , 32 , 33 , 34 ], principal component analysis, (PCA) [ 35 , 36 , 37 , 38 ] etc., play significant roles in investigating the atomic-level mechanism of binding between inhibitors and targets. Conventional MD simulations (cMD) are usually used to obtain conformational samplings of inhibitor–target complexes, but multiple separate MD (MSMD) simulations recently adopted by different work groups can reasonably improve the sampling efficiency of conformations [ 39 , 40 , 41 , 42 , 43 , 44 , 45 ].…”